UHT Milk Market Is on Track To Hit $126,174 Million by 2030

The demand for ultra-high temperature (UHT) milk, sometimes referred to as long-life milk, has a lot of room for expansion. One main factor driving UHT milk sales is the growing habit of consuming milk on the move.

UHT Milk Market Revenue Estimation and Growth Forecast Report

Due to their increasingly hectic schedules, people nowadays are forced to look for alternatives to regular liquid milk, which must be refrigerated and has a finite shelf life.

Get More Insights: UHT Milk Market Revenue Estimation and Growth Forecast Report

By 2030, the UHT milk market will be worth $126,174 million. This is attributable to increased knowledge of this product, which urban young prefer owing to its busy lifestyles, extended shelf life, and ease of use.

Due to its perishable nature, regular milk consumption is declining in both developed and developing countries' metropolitan areas. The ultra-heated milk is used worldwide as an alternative to traditional milk.

The rise in the number of individuals with hectic schedules and the absence of refrigeration facilities in growing nations are the two main drivers of the worldwide industry.

Whole Milk IS Most Popular

The most popular type of milk is whole milk, often known as full-cream milk, and it is normally sold with a fat content of 3.5% or more. This group occupied about 60% of the market. Whole milk is beneficial throughout the formative years because it contains high phosphorus, calcium, and vitamins B1, A, and D.

Due to its great nutritional content, it is primarily ingested by youngsters, teens, nursing moms, and bodybuilders. Whole milk is often used in restaurants and coffee shops since there is a great need for milk with a significant whipping quality.

One of the key drivers of the industry is a scarcity of refrigerated space. Food items that are more prone to bacterial growth need to be refrigerated. Raw milk needs to be kept cold until it's eaten.

Because of the high cost of refrigeration, the scarcity of chilled space, and the protracted power outages, consumers are more prone to use goods that endure a long time without refrigeration in developing countries.

Growing Consumer Demand for Full-Fat UHT Milk

When alternative methods are insufficient, whole milk and cream are subjected to UHT treatments.

For instance, while making whole milk, the cream portion contains fat globules that cannot pass via the microfiltration membrane—it is the first UHT treated before being combined with the microfiltered skim milk to create a product with a longer shelf life.

Toddlers best consume full-cream UHT milk under 2 years old, expectant mothers, and bodybuilders since it contains much more fat than semi-skimmed and skimmed UHT milk.

Direct and Institutional Sales Will Surge

The direct/institutional category will have the greatest CAGR in the coming years. This is a result of rising sales at government agencies and restaurant franchises. Restaurant chains are starting to emerge as important clients to satisfy the milk industry demand, particularly for variations with a larger whipping capacity.

Read More

How Does Rising Demand for Security Enforcement Propels Ballistic Protection Industry?

The ballistic protection industry has garnered $12,478.08 million revenue, and it is projected to generate $19,378.54 million revenue in 2030, advancing at a rate of 5.01%. It is led by the surging use of ballistic protective materials in law and military enforcement organizations across the world. It is ascribed to protecting law enforcement personnel, military personnel, and vehicles from projectiles, mortars, mines, explosives, falling glass, and other dangerous materials.

In addition, these protective materials function in a different way, usually when they are struck by bullets or explosives.

Moreover, the rise in the homeland security forces, such as police, VIP security staff, and first responders, along with the rise in the defense budget boosts the industry growth. Also, governments focus on proliferating and protecting military capabilities due to increasing cross-border disputes.

North America captures the largest industry share of the industry. It is led by rising demand for lightweight armor, surging R&D expenditure, technical advancements, and the presence of key players. The major industry players offer ballistic protection solutions, which include helmets, vehicle armor, shields, and uniforms.

Moreover, celebrities, political leaders, and other famous individuals select private security services, led by increasing security threats, growing terrorist attacks, and cross-border conflicts leading to the increasing requirement for ballistic protection in the Canada and U.S.

On the other hand, the APAC industry is projected to experience rapid growth in the coming years. It is ascribed to increasing defense expenditure in countries such as China, India, Australia, South Korea, and Japan, including the growing economy of the region.

In addition, governments of the above-mentioned countries focus on partnering with the contractors and providing them assistance in the procurement process with financial support and infrastructure.

Therefore, the rising security concerns and growing demand for improving army survivability boost the demand for ballistic protection.

Read More

Rising Prevalence of Gastro-Intestinal Diseases Boosts Microbiome Therapeutics Industry

The microbiome therapeutics industry has garnered $314.4 million revenue in 2021, and it is projected to rise at the rate of 23.1% in the coming years, to capture the $2,036.4 million industry size.

The microbiome plays a substantial role in both types of illnesses gastrointestinal, and non-gastrointestinal, making it a lucrative target for new therapies. In addition, industry growth is ascribed to the potential of digestive-related therapeutics to mitigate the inadequacies in traditional treatment.

There is a higher possibility of such therapeutics to cater to the demand of present therapeutics choices, rise in the illness dimension, participation of academic institutions, rising strategic activities, and recognizing the businesses operating in the field.

Opportunities in the Industry

The presence of innovative players in a smaller number provides numerous opportunities to grow for major stakeholders and attain businesses that involve studying microbiomes for discovering new drugs and drug targets for multiple indications, such as liver disorders, obesity, metabolic disorders, and diabetes.

The key industry players are focusing on strategic alliances and collaborations to expand themselves through product pipelines with efficient R&D methods. In addition, numerous companies have participated in collaborations and partnerships in the last two years, to remain on the competitive edge.

Businesses reduce the selling price of goods and extend state-of-the-art healthcare access to a wider populace section, to propel the usage of digestive health-related therapies. It offers vendors alluring opportunities for growth.

The fecal microbial transplant captures a substantial share of the industry revenue, and it is projected to capture over 84% of the revenue share in 2030. It is owed to the rising fecal microbial transplant usage and the presence of FMT in the capsule form, that has increased the acceptability of the C. difficile infection treatment for patients.

Moreover, the microbiome drugs demand is expected to rise at a higher rate in the coming years. It is led by the rising research activities conducted by research institutes to discover the additional therapeutic FMT uses, a strong pipeline, and the development of advanced medications.

Microbiome therapeutics contribute to gastrointestinal and infectious disease treatment. It contributes more than 92% of the industry share. Moreover, a slew of such treatments focuses on gut-relevant disorders, such as inflammatory bowel disease, C. diff. infection (CDI), and ulcerative colitis, are in the developmental stage and offer massive economic potential in the coming years.

Get More Details Microbiome Therapeutics Market Share

Read More

Why Do We Need Medical Device Analytical Testing Outsourcing?

Several companies of medical devices outsource analytical testing tasks to reduce the costs, hasten the launch of novel products into the analytical testing outsourcing business, and eliminate commercial risks. 

IMDs, or implantable medical devices, are being used more often to improve patient outcomes in terms of health. The balance between complexity, power consumption, reliability, and cost must be struck by IMD designers.

The global demand for medical device analytical testing outsourcing is growing due to the government's increasingly stringent quality certificate regulations. Medical device manufacturers are engaging consultants to assist them in understanding the paperwork and legal requirements for pre-market approval.

The demand for medical device analytical testing outsourcing is predicted to hit $10,904.8 million by 2030. This is due to an increase in the number of small-scale producers of medical devices, increased demand for medical device efficacy and security verification and validation, and the implementation of stringent government regulations.

Increasing Number of Cardiovascular Diseases

Due to the rising frequency of heart problems, there is a high requirement for cardiovascular equipment, which is why outsourcing is expanding. It is estimated that more than 17 million people die each year from cardiovascular diseases. That figure will increase to 23.6 million by 2030.

Moreover, CVDs are quite complex, requiring the safest and most user-friendly diagnostic and therapeutic tools imaginable.

To expand production and outsource the analytical testing process, medical device companies are turning to contract development and manufacturing organizations, along with a growth in the number of patients.

Reprocessed Devices: Why Are They So Popular?

Cleaning up any visible debris, properly sanitizing the equipment, packaging and labeling it, and ultimately holding the reprocessor accountable for any unfavorable effects the item may have been all steps in the reprocessing process.

Even though medical device reprocessing is still relatively new globally, it has already been demonstrated to provide healthcare professionals with several significant benefits.

Orthopedic blades, fixation tools, endotracheal tubes, electrosurgical electrodes, electrophysiology catheters, and ophthalmic knives may all now be recycled in large quantities.

Why Do Hospitals Contract Out Testing for Analyses?

Hospitals' increasing need for medical devices built with emerging technology is a significant factor pushing the use of analytical testing for medical devices among hospitals. These facilities store cutting-edge medical technologies that require thorough analysis and testing to work at their best.

Hospitals are one of the most important target industries for contract development and manufacturing organizations since they are the principal consumers of refurbished medical equipment, which necessitates analytical services.

Get More Details Medical Device Analytical Testing Outsourcing Market Competitive Landscape

Read More

Why Will Large Hospitals Drive Hospital Risk Management Market?

The major drivers in the global hospital risk management market are the high prevalence of long-term diseases and the increasing count of medical errors. In 2021, the market was valued at $1,115.4 million, and it is projected to touch $3,482.3 million by 2030. The market will advance at a 13.5% CAGR from 2021 to 2030. Medical errors lead to approximately 3 million deaths every year in comparison to mortality from malaria, HIV, and tuberculosis. Furthermore, extensive governmental support, the increasing integration of information technology in hospitals and clinics, and swift modernization will drive the market.

Furthermore, the second-largest shareholder in the hospital risk management market is the workflow management category, accounting for about one-fifth of the total revenue, in 2021. There is huge pressure on the healthcare infrastructure because of the surging incidence of long-term illnesses. Around 70% of the global deaths are because of chronic diseases per year, accounting for approximately the death of 40 million people each year. Apart from offering better effectiveness in medical data control, the category improves internal operations via automation.

By 2030, the biggest share in the hospital risk management market will be held by the large hospital category, accounting for approximately 60% of the total market share. This can be ascribed to a swift integration of EHRs in the healthcare centers., surging hospital expenditure, and an increasing count of large hospitals. To remove the medical errors, there is a dire need for hospital risk management to enhance the operations of EHR systems. The highest hospital bed density is witnessed in Japan with approximately 13 beds for every 1000 people.

In 2021, the global hospital risk management market was led by North America. This is because of the surging adoption of data science to ease the workflow in healthcare centers, the paradigm shift of the on-premises risk management to cloud-based solutions, and the surging count of market players in the U.S. There is a high investment in the healthcare sector due to rising medical errors. Approximately $40 billion is spent on patients bothered with medication errors.

Hence, an increasing count of medical errors and a high prevalence of long-term diseases will provide lucrative opportunities to the market players to gain a competitive edge.

Get More Details Hospital Risk Management Market Growth Factors, Company Profile Analysis

Read More

Ocular Implants Market Trends, Drivers, and Growth Forecast to 2030

Our vision gradually declines as we age. Now and then, people need reading glasses or additional visual aids as their age increases, while others face the clouding of their natural lenses. Patients with weakened vision because of cataracts do not have to live with cloudy vision throughout their life. They can get a renewed sight in the form of an intraocular lens implant.

 This implant could lessen the need for corrective eyewear when the natural lens is substituted with an intraocular lens. So, can the intraocular lens be detached and substituted, what is the lasting duration of cataract lenses? If you have queries about IOLs, you can get some of your questions answered by reading this blog.

What is the Lasting Duration of cataract lenses?

Consequently, how long do cataract lenses last? Different from the eye's natural lenses, IOLs do not collapse and are never required to be replaced. To reap these lifelong aids, patients should follow any post-operative care instructions given by the doctor after the surgery. Full recovery can occur in 1 – 2 days, but this is  subject to on your original eyesight and primary health conditions. The doctors can schedule follow-up arrangements to ensure that the healing process is going as planned. 

You can always follow these recovery instructions after the laser cataract surgery:

• Get an adequate amount of rest and sleep

• Avoid rubbing or touching your eyes

• Take the prescribed medications as directed by the physician

• Wash your hands thoroughly before making use of any drops

With the increase in the number of people suffering from cataracts and various other kinds of problems related to the eyes, the demand for ocular implants is on the rise. It will reach a value of above $17,279 million by 2030.

Get More Details Ocular Implants Market Growth Factors, and Demand Forecast to 2030

Read More

Increasing Incidences of Organ Failure Leads to Rising Demand for Transplantation

Transplantation in healthcare helps in saving the lives of numerous people whose organs, or cells have stopped functioning. When no other alternative works, human cells, tissues, or organs are transplanted.

Transplantation can be defined as tissue, organ, or cell group removal from donor to recipient, or positioning from one site to another in the same person. In 2021, the transplantation industry contributes $13,605.9 million, and it is projected to advance at a rate of 9.2% and capture $30,117.5 million in 2030.

Transplantation is not a simple healthcare procedure in medicine. It involves numerous complications, as the transplantation of organs or tissues from one person to another, may cause rejection from the recipient’s immune system, which may destroy the donated organ or tissue, to prevent such immune response medication is required. Under such conditions, treatment may vary depending on the organ and tissue being transplanted, compatibility level between recipient and donor, and various other factors.

 Some of the major transplantation in healthcare

 

• Patients suffering from corneal blindness can get their eyesight back with corneal grafting
• Hematopoietic stem cell transplantation can help in curing congenital diseases along with leukemia.
• Recipient patients of human heart valve transplantation do not require to undergo long-term anti-coagulation therapy, done under the best replacement situation.
•  

Xenotransplantation: Living cells, organs, or tissues of animals or humans, along with cells, body fluids, tissues, or organs ex vivo with xenogeneic materials being alive, are capable of constituting an alternative to human origin material, and fulfill the requirement for human material for transplantation.

 Tissue Transplantation in the Same Person

The most prevalent transplantation is tissue transplantation, in which one tissue from one part of the body is transplanted to another part through autograft, the process is known as autotransplantation.

 Several types of autografts:

 Skin Graft: It involves the usage of healthy skin to support the healing of the wound or burn on another body part.

 Blood Vessel Graft: It helps in providing an alternative passage for blood flow to bypass a blocked artery, such as heart bypass surgery.

 Bone Graft: Bone grafting helps in reconstructing the damaged area of the body, such as in spinal fusion.

 Bone Marrow Graft: For instance, bone marrow needs to be collected in cancer patients before, they undergo chemotherapy. As, after high-dose of chemotherapy results in the replacement of blood stem cells.

The increasing incidences of chronic diseases, such as solid tumors, myelodysplastic disorders, plasma cell disorders, immune system disorders, and kidney failures, are leading to the growing prevalence of transplantation.

Increasing awareness of organ donations, technological advancements such as kidney transplantation with robot assistance, and rising success rates in organ transplantation, increase people’s confidence to undergo organ transplantation.

The rising elderly population increases the demand for orthobiologics for reducing pain, fast tissue healing, and restoration of normal functioning. Numerous, startup companies are receiving investments to expand their operations. For example, a shoulder replacement manufacturer, Catalyst OrthoScience raised $12.3 million in the financing round and utilized it to launch Archer 3D Targeting Imaging Software and Archer R1 Reverse Shoulder System.

Therefore, the rising elderly population increases the prevalence of transplantation, with growing incidences of organ failure, or chronic diseases.

 Read More Transplantation Market Scope and Size

Read More